Luís Henrique Santos Canani

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity

Louis J. Aronne, Naveed Sattar, Deborah B. Horn et al. · JAMA · 2023 · 709 citations · Full text

Agriculture, Pharmacotherapy, Clinical Pharmacology +16

Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial

Helena W. Rodbard, Julio Rosenstock, Luís Henrique Santos Canani et al. · Diabetes Care · 2019 · 446 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Genome-Wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes

Marcus G. Pezzolesi, G. David Poznik, Josyf C. Mychaleckyj et al. · Diabetes · 2009 · 291 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial

Thomas R. Pieber, Bruce W. Bode, Young Min Cho et al. · The Lancet Diabetes & Endocrinology · 2019 · 274 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

The Type 2 Deiodinase A/G (Thr92Ala) Polymorphism Is Associated with Decreased Enzyme Velocity and Increased Insulin Resistance in Patients with Type 2 Diabetes Mellitus

Luís Henrique Santos Canani, Clarissa Capp, José Miguel Dora et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 207 citations · Full text

Medicine, Endocrinology, Molecular Genetics +16